山东医药
山東醫藥
산동의약
SHANDONG MEDICAL JOURNAL
2014年
38期
5-7
,共3页
王立新%丁洁%陈晓平%胡小山%姚雨石
王立新%丁潔%陳曉平%鬍小山%姚雨石
왕립신%정길%진효평%호소산%요우석
地西他滨%淋巴瘤/白血病EL4细胞%细胞增殖%细胞表面共刺激分子
地西他濱%淋巴瘤/白血病EL4細胞%細胞增殖%細胞錶麵共刺激分子
지서타빈%림파류/백혈병EL4세포%세포증식%세포표면공자격분자
decitabine%lymphoma EL4 cells%proliferation%inhibition%costimulatory molecules
目的:探讨国产地西他滨( DEC)对小鼠淋巴瘤/白血病细胞EL4的体外细胞毒作用及对共刺激分子CD80表达的影响。方法小鼠淋巴瘤/白血病EL4细胞系( EL4细胞)分别用进口地西他滨( DAC)和DEC(终浓度均为0.25μM)连续体外处理3 d。采用瑞氏吉姆萨染色法观察细胞形态变化,流式细胞仪检测细胞表面共刺激分子CD80表达,CCK8法测细胞增殖抑制情况。结果 DAC和DEC均可引起EL4细胞明显的形态改变,二者作用无明显差异;DAC和DECF干预后EL4细胞CD80表达均升高,细胞增殖受抑制;二者的作用无显著差异。结论 DAC和DEC体外致EL4细胞形态改变、增殖抑制及刺激CD80表达的能力无明显差异;提示二者体内抗肿瘤作用及诱导特异性抗肿瘤免疫应答能力相近。
目的:探討國產地西他濱( DEC)對小鼠淋巴瘤/白血病細胞EL4的體外細胞毒作用及對共刺激分子CD80錶達的影響。方法小鼠淋巴瘤/白血病EL4細胞繫( EL4細胞)分彆用進口地西他濱( DAC)和DEC(終濃度均為0.25μM)連續體外處理3 d。採用瑞氏吉姆薩染色法觀察細胞形態變化,流式細胞儀檢測細胞錶麵共刺激分子CD80錶達,CCK8法測細胞增殖抑製情況。結果 DAC和DEC均可引起EL4細胞明顯的形態改變,二者作用無明顯差異;DAC和DECF榦預後EL4細胞CD80錶達均升高,細胞增殖受抑製;二者的作用無顯著差異。結論 DAC和DEC體外緻EL4細胞形態改變、增殖抑製及刺激CD80錶達的能力無明顯差異;提示二者體內抗腫瘤作用及誘導特異性抗腫瘤免疫應答能力相近。
목적:탐토국산지서타빈( DEC)대소서림파류/백혈병세포EL4적체외세포독작용급대공자격분자CD80표체적영향。방법소서림파류/백혈병EL4세포계( EL4세포)분별용진구지서타빈( DAC)화DEC(종농도균위0.25μM)련속체외처리3 d。채용서씨길모살염색법관찰세포형태변화,류식세포의검측세포표면공자격분자CD80표체,CCK8법측세포증식억제정황。결과 DAC화DEC균가인기EL4세포명현적형태개변,이자작용무명현차이;DAC화DECF간예후EL4세포CD80표체균승고,세포증식수억제;이자적작용무현저차이。결론 DAC화DEC체외치EL4세포형태개변、증식억제급자격CD80표체적능력무명현차이;제시이자체내항종류작용급유도특이성항종류면역응답능력상근。
Objective To compare the influence of cytotoxicity and CD80 expression in EL4 cells, following in vitro treatment with decitabine ( DEC) manufactured internal.Methods EL4 cell line was treated with Dacogen ( DAC, manu-factured by Xian Janssen Pharmaceutical Ltd) or DEC (final concentration 0.25μmol/L) in vitro for 3 days.Morphology was analysised by method of Wright-Gimesa staining.CD80 expression was detected by method of flow cytometry.Cell pro-liferation was detected by method of CCK-8 kit.Results DAC and DEC treatment resulted in similar morphological chan-ges in EL4 cells.Moreover, effects of CD80 expression and inhibited proliferation induced by both DAC and DEC in EL4 cells were no significant differences (P>0.05).Conclusions There was no significant difference between DAC and DEC in the ability of change cellular morphology, inhibit proliferation and stimulate CD80 expression in mouse-lymphoma/leuke-mia cell EL4 cultured in vitro, which indicates the effects of the two drugs were similarity in both cytotoxic effect on tumor cells and stimulation of anti-tumor immune response when administered in vivo.